Here's Why Tenet Healthcare (THC) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 26, 2026

Tenet Healthcare Corporation's Regulatory Woes Don't Put It In The ER

Tenet Healthcare Corporation remains a compelling Buy, supported by strong financial performance and deeply discounted valuation versus peers. Despite a recent 22.7% stock decline and regulatory headwinds, THC's Ambulatory Care segment shows resilience, with revenue up from $1.19B to $1.32B and profit growth. Management guides for 2026 revenue of $21.5B–$22.3B, EBITDA of $4.485B–$4.785B, and adjusted net profits of $1.425B–$1.625B.

Seeking Alpha • May 26, 2026

Here's Why Tenet Healthcare (THC) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 25, 2026

Is Tenet (THC) a Solid Growth Stock? 3 Reasons to Think "Yes"

Tenet (THC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • May 22, 2026

Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know

Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Investment Research • May 21, 2026

Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • May 20, 2026

Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Zacks Investment Research • May 19, 2026

Wall Street Analysts Think Tenet (THC) Could Surge 26.16%: Read This Before Placing a Bet

The mean of analysts' price targets for Tenet (THC) points to a 26.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research • May 18, 2026

Is Tenet Healthcare (THC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • May 15, 2026

Tenet Healthcare Corporation (THC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Tenet Healthcare Corporation (THC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 14, 2026